期刊文献+

多孔羟基磷灰石微球对药物的吸附性质 被引量:1

Drug adsorption properties of porous hydroxyapatite microspheres
原文传递
导出
摘要 目的考察多孔羟基磷灰石微球对药物的吸附性质。方法采用溶液吸附法研究市售羟基磷灰石微球对药物的吸附性质。以氯化锶为标记物,用扫描电镜-能谱分析仪定点扫描微球内锶的分布情况,氮吸附法测定微球的比表面积和孔径。结果可与羟基磷灰石上的钙离子螯合的药物吸附量相对较高,而依靠氢键或电荷间相互作用、发生物理吸附的药物吸附量偏低,难溶性药物吸附药量普遍低于水溶性药物。市售微球孔径约为30 nm,属于介孔材料,药物多分布在微球的表层。结论阐明了羟基磷灰石微球对不同类型药物的吸附特征,为其作为药物载体提供依据。 Objective To study the drug adsorption properties on porous hydroxyapatite microspheres(HAP-MS).Methods The absorption of various drugs on commercial HAP-MS was examined using solution absorption method.The absorption of strontium on HAP was analyzed using SEM-EDX,and the specific surface area and pore size of HAP-MS were determined with nitrogen adsorption method.Results The amount of drugs adsorbed on HAP-MS was relatively high for drugs which can chelate with calcium ion,while only small amount of drug was adsorbed for drugs which can only physically adsorb via hydrogen bonding or charge interaction.The amount of insoluble drugs adsorbed on HAP-MS was generally lower than that of water soluble drugs.The commercial HAP-MS was mesoporous material with a most probable pore size of 30 nm,and the drugs adsorbed mainly distributed on the outer layer of HAP-MS.Conclusions The drug adsorption properties on HAP-MS are determined,the results may provide valuable implication for the application of HAP-MS in drug delivery.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2012年第8期586-590,共5页 Journal of Shenyang Pharmaceutical University
关键词 羟基磷灰石 微球 药物吸附 介孔 hydroxyapatite; microsphere; drug adsorption; mesoporous
  • 相关文献

参考文献15

  • 1ANDERSON J M, SHIVE M S. Biodegradation and biocompatibility of PLA and PLGA microspheres [ J ]. Adv Drug Deliv Rev, 1997,32:231 - 241.
  • 2KAWASAKI T. Fundamental study of hydroxyapatite high performance liquid chromatography [ J ]. Chroma- tography, 1990,515 : 125 - 128.
  • 3MAA J, WANG C, PENG K W. Electrophoretic depo- sition of porous hydroxyapatite interface [ J ]. Biomate- rials ,2003,24:3505 - 3510.
  • 4HU Qiao-ling, LI Bao-qiang, WANG Mang, et al. Preparation and characteration of biodegradable chi- tosan/hydroxyapatite nanocomsite rods via in situ hy- bridization: a potential material as fixation of bone fracture [ J ]. Biomaterials, 2004,25 (5) : 779 - 785.
  • 5ZHANG Jing-xian, MAEDA M, KOTOBUKI N, et al. Aqueous processing of hydroxyapatite [ J ]. Materials Chemistry and Physics, 2006,99 : 398 - 404.
  • 6DAVID M, DUFFY M D. Complication of fillers:O- verview [ J ]. J Dermatol Surg, 2005,12 : 1226 - 1633.
  • 7郑步中,吕晓迎,王彭延.羟基磷灰石在口腔保健领域的应用[J].国外医学(生物医学工程分册),2004,27(1):26-29. 被引量:16
  • 8HABRAKENW J E M, WOLKE J G C, JANSEN J A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering [J]. Advanced Drug Delivery Reviews ,2007,59 ( 4 - 5 ) :234 - 248.
  • 9GINEBRA M P, TRAYKOVA T. Calcium phosphate cements as bone drug delivery systems : A review [ J ]. J Controlled Release ,2006,113 (2) : 102 - 110.
  • 10NIE He-rnin, WANG Chi-hua. Fabrication and charac- terization of PLGA/HAP composite scaffolds for de- livery of BMP-2 plasmid DNA [J]. J Controlled Re- lease ,2007,120 : 111 - 121.

二级参考文献56

  • 1冯德厚,李毅苹.羟基磷灰石与美容牙膏[J].牙膏工业,2004,14(3):16-18. 被引量:4
  • 2周永德.光固化牙本质粘结剂治疗牙齿过敏症的临床观察[J].现代口腔医学杂志,1994,8(4):243-244. 被引量:2
  • 3王菊如,张超武,李华,王荣江.生物活性羟基磷灰石牙膏的研制[J].齐齐哈尔轻工业学院学报,1996,12(2):26-28. 被引量:4
  • 4徐铮奎.补牙牙膏[J].牙膏工业,1998,(2):63-65.
  • 5YANG Piao-ping, QUAN Ze-wei, LI Chun-xia, et al. Bioactive, luminescent and mesoporous europium - doped hydroxyapatite as a drug carrier[J]. Biomaterials, 2008,29 (32) :4341 - 4347.
  • 6STSNIK C V, DIMITRIJEVI C S, ANTI C-STANKOVI C J, et al. Synthesis, characterization and antirnicrobial activity of copper and zinc-doped hydroxyapatite nanopowders[ J ]. Applied Surface Science, 2010,256 (20) :6083 - 6089.
  • 7WANG Ai-li, YIN Heng-bo, LIU Dong, et al. Effects of organic modifiers on the size-controlled synthesis of hydroxyapatite nanorods [ J ]. Applied Surface Science,2007,253(6) :3311 -3316.
  • 8WANG Ai-li, YIN Heng-bo, LIU Dong, et al. Sizecontrolled synthesis of hydroxyapatite nanorods in the presence of organic modifiers [ J ]. Materials Letters, 2007,61 (10) :2084 - 2088.
  • 9LI Hong, ZHU Min-ying, LI Li-hua, et al. Processing of nanocrystalline hydroxyapatite particles via reverse microemulsions [ J ]. J Mater Sci, 2008,43 ( 1 ) : 384 - 389.
  • 10SAHA S K, BANERIEE A, Banerjee S, et al. Synthesis of nanocrystalline hydroxyapatite using surfactant template systems: role of templates in controlling morphology [ J ]. Materials Science and Engineering C, 2009,29 (7) : 2294 - 2301.

共引文献21

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部